SCHEMBL565014

SCHEMBL565014

CC(C)CN(Cc1cc(Cl)c2c(c1)CCCCO2)C(=O)C(C)CNCCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.50
ALDH1A1 P00352 1/20 0.35
ADRB3 P13945 3/20 0.35
ADRB1 P08588 2/20 0.33
ADRB2 P07550 4/20 0.33
DRD2 P14416 2/20 0.32
DRD1 P21728 2/20 0.32
DRD4 P21917 2/20 0.32
DRD3 P35462 2/20 0.32
SLC2A1 P11166 1/20 0.32
NPC1 O15118 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PKM P14618 1/20 0.32
PAX8 Q06710 1/20 0.32
KLF5 Q13887 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ANPEP P15144 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10107414 0.92 PROKR2 (0.55) PROKR2ALDH1A1DRD2DRD4DRD3
SCHEMBL565040 0.87 PROKR2 (0.52) PROKR2ADRB3ADRB1ADRB2
SCHEMBL565356 0.86 PROKR2 (0.47) PROKR2ALDH1A1HPGDSMN1; SMN2
SCHEMBL565013 0.85 PROKR2 (0.44) PROKR2ALDH1A1MEN1KMT2AHPGD
SCHEMBL10107480 0.82 PROKR2 (0.58) PROKR2MEN1KMT2A
SCHEMBL10107483 0.81 PROKR2 (0.54) PROKR2ALDH1A1MEN1KMT2AHPGD
SCHEMBL565109 0.79 PROKR2 (0.69) PROKR2ALDH1A1NPC1MEN1KMT2A
SCHEMBL565524 0.79 PROKR2 (0.69) PROKR2ALDH1A1NPC1MEN1KMT2A
SCHEMBL15693909 0.79 PROKR2 (0.69) PROKR2ALDH1A1NPC1MEN1KMT2A
SCHEMBL565461 0.79 PROKR2 (0.59) PROKR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885ALDH1A1 4725/4885ADRB3 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.